DEVELOPING NATIONAL FORMULARIES BASED ON THE WHO MODEL FORMULARY Tisocki K, Laing RL, Hogerzeil H, Mehta DK, Ryan RSM.

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

Medication Management
MOSS 2007 Document Management Adam McCarthy 1 st April 2009.
Configuration Management
Paul Mundy Adapting the writeshop process Paul Mundy Independent specialist in development communication
CQC registration for providers of Primary Dental Services Medicines Management Caroline Crouch NHS Dorset.
MEDICINES SELECTION & FORMULARY MANAGEMENT
ALIA Inter-Library Lending Expert Advisory Group (ILLEAG) Thomas Girke Manager, Information Support CSIRO Information Management & Technology.
SOURCES OF PHARMACEUTICAL INFORMATION. 1-Pharmacopeias Pharmacopoeia is a book containing an official list of the drugs used in medicine together with.
1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
Entrenching the KNH Formulary to Clinical Practice DR WK SIGILAI MTC CHAIR.
MICS Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Overview of MICS Tools, Templates, Resources, Technical Assistance.
Clinical Pharmacy Basma Y. Kentab MSc..
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
 needs to be met  existing resources  content outline  contributor team  contract details  timeline.
By: Farzad Dadgari Soil and Environmental Specialist SWHISA.
RPS Publishing Dr. Laszlo Horvath. Overview Brief History Brief History RPS Publishing – Imprints RPS Publishing – Imprints Pharmaceutical Press Products.
Presenter name. Ryan Brandon Exan Group What’s New with axiUm New Features in axiUm Patient Self-Service Options Future Plans axiUmSupport.com.
Guidance for Editors Working with care maps © 2008 Map of Medicine Ltd. Commercial and in confidence.
NATA Athletic Training Educational Competencies 4th Edition 2006.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
RESIDENT PROJECTS ROBERT LEONHARD QUALITY IMPROVEMENT MANAGER.
D1.HGE.CL7.01 D1.HGA.CL6.08 Slide 1. Introduction Design, prepare and present reports  Classroom schedule  Trainer contact details  Assessments  Resources:
CD ROMs for Pharmaceutical use Patrick Bongo BSc (Hons), MSc, PGCE, MBCS.
An introduction to MedicinesComplete By Christos Skoutas.
Training Role Module 8 – User Admin Ver. 10 Oct 2009.
ACCESS TO MEDICINES - POLICY AND ISSUES
Service Manager 7.10 Knowledgebase Demo “Knowledge is power”
Swets eBook Training Swets eBook Training Helen Carver Sales Office Manager, Digital Content 16 th June 2008.
NORTH AMERICAN HEALTHCARE COMMITTEES. POLICY Facility shall have at least the following committees: Resident Care Infection Control Pharmaceutical Quality.
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.
Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
COMPARATIVE ANALYSIS OF SELECTED ESSENTIAL DRUG LISTS AZIZ JAFAROV/RICHARD LAING.
Drug Information Services. Aims of the Course To introduce the students how to locate, evaluate drug information’s systematically, manage and distribute.
Candidates: Administrators:
Selection of essential medicines Richard Laing and Deidre Dimancesco TBS 2011 Department of Essential Medicines & Pharmaceutical Policies TBS 2008.
© 2011 Pearson Education, Inc., publishing as Longman Publishers. 1 Chapter 6 An Overview of the Technical Writing Process Technical Communication, 12.
Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,
Pethidine prescribing in the ED… Let’s be rational! Kaye KI, Maxwell DJ, Graudins L, on behalf of the the NSW Therapeutic Assessment Group (NSW TAG) Drug.
Adapting the writeshop process Paul Mundy Independent specialist in development communication
Accreditation (AdvancED) Process School Improvement Activities February 2016 Office of Service Quality Veda Hudge, Director Donna Boruch, Coordinator of.
ANALYZING PEER REVIEW OF WRITING FEEDBACK Kathleen A. Harper Engineering Education Innovation Center The Ohio State University
Introduction Training. Training contents Introduction What is LXRMTK? How can LXRMTK be used? Where can LXRMTK be used? Who can use LXRMTK? History of.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Pharmacy & Therapeutics Committee Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016.
Pharmacy & Therapeutics Committee
Clinical Knowledge Summaries Overview
RPS Publishing Presentation to INFORMATIO MEDICATA 2006 by Maryam Kazemi 17 October 2006.
Evaluating Australia‘s National Strategy for Quality Use of Medicines
Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.
Introduction to Clinical Pharmacy
Sohar University Quality Unit
Pharmacy & Therapeutics Committee
WHO Model Formulary (WMF)
Policy Development in Yukon Education
A Guide for Professional Staff
Comp 20 - Training & Instructional Design
A Guide for Professional Staff
Lippincott’s Nursing Advisor
Session 2. Developing and Maintaining a Formulary
APOLLOJAMES LECTURER NANDHA COLLEGE OF PHARMACY
Pharmacy & Therapeutics Committee
Fiscal policy program Presented by Cindy Draper, Fiscal Policy Officer – Training Days 2018 Introduce myself This session is to provide an overview of.
Introduction to Fiscal Policy Program
Pharmacy & Therapeutics Committee
Presentation transcript:

DEVELOPING NATIONAL FORMULARIES BASED ON THE WHO MODEL FORMULARY Tisocki K, Laing RL, Hogerzeil H, Mehta DK, Ryan RSM

WHO Model Formulary (WMF) Purpose  To promote safe and cost-effective use of medicines included in the WHO Essential Medicines List  To serve as model for national, local or institutional formularies Brief history 1995 recommendation to develop Model Formulary by WHO Expert Committee 2000 Start of validation and final editing of draft 2002 first edition out in print, CD-Rom and online on the WHO website 2004 the second revised edition is now available in print and online the CD-Rom will have files in multiple languages and manual on how to produce a National Formulary

WHO Model Formulary (WMF)  Reflects evidence-based recommendations of WHO and other reputable clinical guidelines  Validated using current, reputable drug information resources & WHO documents  Design and organization is modeled on the successful and widely used British National Formulary (BNF)  Produced in collaboration between  BNF editorial team, Royal Pharmaceutical Society of Great Britain and  The Essential Medicine Department of WHO

Anatomy of WMF Front matter  General Advice to prescribers  e.g. prescription writing, adherence  Essential Medicines List  List of deletion, additions, changes to Essential Medicines List Main body  27 Sections organized into therapeutic categories  Within each section general discussion of therapeutic options and safety issues, followed by individual monographs Rear Matter  Appendices:  Interactions, Pregnancy, Breastfeeding, Renal impairment, Hepatic impairment  Index: includes disease and drug terms

How the WMF can be used? As… a resource and model for developing national and institutional formularies a high quality, independent drug information resource during the review of existing formularies an essential medicines/ clinical guideline resource for individual prescribers

Developing/maintaining national formularies based on WMF Planning Development Production/ of draft Distribution Formulary & Advisory Committee Editorial team Agree on plan & budget Start by using WMF text Add local info Review and approve final text Final editing & layout Print Distribute Implement Evaluation & Review using updated WMF

Important local information in national formulary Front matter  Policies and procedures of National Formulary Committee  Instruction on how to use formulary  National policies & regulations on prescribing/ dispensing Main body  Local guideline recommendations  Local, product-specific information  New monographs, if local medicine is not in WMF Note: Use local advisory committee for writing / reviewing draft Rear matter  Additional safety, pharmaceutical and administrative info e.g. incompatibilities, poisoning information, dose calculators, ADR reporting form, contact details

Production issues  WMF text will be available as Word® files for developing local formulary text  Need skilled editor when modifying, deleting WMF text in order to maintain integrity of information  Careful copy-editing and proofreading  Design a user friendly format  Slim, light, durable  Select good quality, affordable printing methods

Once the printed copy is out… It is essential to have:  Good distribution mechanism  Implementation: launch, promotional, training activities  Evaluation to measure impact of formulary on local prescribing  Mechanism for collecting feed-back from users  Carefully document errors during time between revisions  Plans for next review and update

Review & Update  Planning for revisions – WMF will be updated every two years  Formulary revision may be linked to national guidelines review  Updates of WMF should be checked for changes, especially in general therapeutic information section  Consider information from evaluation and feed-back from users  Extensive involvement of local experts in review and approval of updated text is important

Summary  WMF provides current evidence-based therapeutic and medicine information  Using existing WMF files in development of local formulary can greatly reduce workload and ensure inclusion of valid information but  careful planning,  skilled editorial team  involvement of local experts  adequate resources and time will be still essential for successful production and implementation of local formulary